Browsing by Author "Bilici, Ahmet Erkan"
Now showing items 1-10 of 10
-
Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade
Ölmez, Ömer Fatih; Kınıkoğlu, Oğuzcan; Helvacı Yılmaz, Nesrin; Bilici, Ahmet Erkan; Çubukçu, Erdem; Şeker, Mesut Metin; Çakır, Tansel; Yıldız, Özcan; Hamdard, Jamshid (SAGE Publications Ltd, 2019)Paraneoplastic neurological syndrome is associated with anti-Ri antibodies, which are typically present with opsoclonus–myoclonus–ataxia. Human epidermal growth factor receptor 2 (HER2) overexpression is present in 15%–25% ... -
Clinical role of 18F-FDG-PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: is there any effect of FDG-PET/CT in patients' management?
Bilici, Ahmet Erkan; Şeker, Mesut; Öven Ustaalioğlu, Bala Başak; Aslan Canpolat, Nesrin; Tekinsoy, Bülent; Salepçi, Taflan; Gümüş, Mahmut (Oxford University Press, 2010)... -
Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?
Bilici, Ahmet Erkan; Öven Ustaalioğlu, Bala Başak; Şeker, Mesut; Aslan Canpolat, Nesrin; Tekinsoy, Bülent; Salepçi, Taflan; Gümüş, Mahmut (Springer, 2010)The aim of this study was to evaluate the clinical value of FDG PET/CT in patients with suspected ovarian cancer recurrence as compared with diagnostic CT, and to assess the impact of the results of FDG PET/CT on treatment ... -
The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival
Öven Ustaalioğlu, Bala Başak; Balvan, Özlem; Bilici, Ahmet Erkan; Develi, Ahmet Çağrı; Aliustaoǧlu, Mehmet; Vardar, Fugen; Erkol, Burçak (Springer-Verlag, 2015)In the literature, small number of study has addressed time of recurrence in breast cancer. We analyzed clinicopathological factors predicting early or late recurrence in breast cancer patients and also prognostic factors ... -
Medication errors in chemotherapy preparation and administration: A survey conducted among oncology nurses in Turkey
Ulaş, Arife; Sılay, Kamile; Akıncı, Sema; Dede, Didem Şener; Akıncı, Muhammed Bülent; Şendur, Mehmet Ali; Çubukçu, Erdem; Çoşkun, Hasan Şenol; Deǧirmenci, Mustafa; Utkan, Güngör Ör; Özdemir, Nuriye Yıldırım; Işıkdoğan, Abdurrahman; Büyükçeli̇k, Abdullah; İnanç, Mevlüde; Bilici, Ahmet Erkan; Odabaşı, Hatice; Cihan, Şener; Avcı, Nilüfer; Yalçın, Bülent (Asian Pacific Organization for Cancer Prevention, 2015)Background: Medication errors in oncology may cause severe clinical problems due to low therapeutic indices and high toxicity of chemotherapeutic agents. We aimed to investigate unintentional medication errors and underlying ... -
Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: Real-life practice outcomes
Esin, Ece; Çakmak Öksüzoǧlu, Berna; Bilici, Ahmet Erkan; Çiçin, İrfan; Köstek, Osman; Kaplan, Mehmet Ali; Aksoy, Sercan; Aktaş, Burak Yasin; Özdemir, Özlem; Alacacıoğlu, Ahmet; Çabuk, Devrim; Sümbül, Ahmet Taner; Sakin, Abdullah; Paydaş, Semra; Yetişir, Ersin; Er, Özlem; Korkmaz, Taner; Yıldırım, Nilgün; Şakalar, Teoman; Demir, Hacer; Artaç¸, Mehmet; Karaaǧaç, Mustafa; Harputluoǧlu, Hakan; Bilen, Ebru; Erdur, Erkan; Deǧirmencioǧlu, Serkan; Aliyev, Altay; Çil, Timuçin; Olgun, Polat; Başaran, Gül Atalay; Gümüşay, Özge; Demir, Atakan; Tanrıkulu, Eda; Yumuk, Perran Fulden; İmamoğlu, İnanç; Oyan, Başak; Çetin, Bülent Eren; Haksöyler, Veysel; Karadurmuş, Nuri; Ertürk, İsmail; Evrensel, Türkkan; Yılmaz, Hasan; Beypınar, İsmail; Koçer, Murat; Pilancı, Kezban Nur; Şeker, Mesut Metin; Ürün, Yüksel; Yıldırım, Nuriye O.; Eren, Tülay; Demirci, Umut (Springer, 2019)PurposeIn this study, we aimed to describe the real-life practice outcomes of pertuzumab-trastuzumab-taxane (PTT) combination in visceral organ metastatic, trastuzumab-naive breast cancer (BC) patients.MethodsThis study ... -
Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: Multicenter experiences
Ustaalioğlu Öven, Başak Bala; Ünal, Olçun Ümit; Turan, Nedim; Bilici, Ahmet Erkan; Kaya, Serap; Eren, Tülay; Ulaş, Arife; İnal, Ali; Berk, Veli; Demirci, Umut; Alıcı, Süleyman; Bal, Öznur; Benekli, Mustafa; Gümüş, Mahmut (Asian Pacific Organization for Cancer Prevention, 2013)Surgery is the only curative treatment for operable non-small lung cancer (NSCLC) and the importance of adjuvant chemotherapy for stage IB patients is unclear. Herein, we evaluated prognostic factors for survival and factors ... -
Prognostic factors for operated gallbladder cancer
Öven Ustaalıoğlu, Bala Başak; Bilici, Ahmet Erkan; Şeker, Mesut Metin; Kefeli, Umut; Aydın, Dinçer; Çelik, Serkan; Demir, Tarık; Erkol, Burçak (Humana Press Inc., 2019)Purpose: The prognosis of gallbladder cancer is poor. Lymph node metastasis and the stage are known to be the strongest prognostic factors for survival. The aim of this study was to determine the importance of complementary ... -
Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy
Aydın, Dinçer; Bilici, Ahmet Erkan; Yavuzer, Dilek; Kefeli, Umut; Tan, A.; Ercelep, Özlem Balvan; Mert, Aslıhan Güven; Yüksel, Sinemis; Özçelik, Melike; Işık, Deniz; Sürmeli, Heves; Odabaşı, Hatice; Aliustaoǧlu, Mehmet (Springer-Verlag, 2015)A disintegrin and metalloproteinase (ADAM) 17 has been indicated to be an indispensable regulator of cellular events from proliferation to migration. Although prognostic importance of ADAM17 expression has been investigated ... -
The relationship between positron emission tomography-computed tomography imaging and histopathological features of thyroid incidentalomas detected during follow-up for primary malignancy
Ustaalıoğlu Öven, Başak; Kılıçoğlu, Zeynep Gamze; Bilici, Ahmet Erkan; Tatoǧlu, Mehmet Tarık; Canberk, Şule; Tilki, Metin; Aker Vardar, Fügen (Wolters Kluwer Medknow Publications, 2019)Aim of the Study: While the rate of thyroid incidentaloma detected on positron emission tomography (PET) was reported as 4%, the malignancy rate was 14%u50%. We evaluated the thyroid nodules which were detected by ...
